Tissue Repair Start-Ups Fill Orthopedics' Gaps
Article preview reprinted from Start-Up - April, 2009
Technologies for total joint repair, the backbone of the orthopedics industry, have occupied most of the development resources of orthopedic companies, but there are gaps in the continuum of care when it comes to tendon and ligament repair.
Tissue Repair Start-Ups Fill Orthopedics' Gaps
Article preview reprinted from Start-Up - April, 2009
ACL reconstruction and rotator cuff repair thus are attractive niches for start-ups, worth anywhere from $500 million to $1 billion. Soft tissue repair expertise is outside the core skill-sets of big ortho, but those companies have been willing to partner and acquire smaller innovative players. Today, the opportunity is even more attractive; sports medicine--the realm of soft tissue repair--enjoys an economic resiliency not seen in total joint replacement. Ligament tears more closely resemble trauma applications, which must be treated as soon as possible.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed. Subscribe to Start-Up.
Companies mentioned in this article:
ArthroCare Corp.
BioProtect Ltd.
BioSurface Engineering Technologies Inc.
Biomet Inc.
Biomet Sports Medicine Inc.
Cayenne Medical Inc.
ConMed Corp.
ConMed Linvatec
Core Essence Orthopaedics Inc.
Covidien Ltd.
Scandius BioMedical Inc.
Harvard University
Harvard Medical School
ISTO Technologies Inc.
Invibio Inc.
Johnson & Johnson
DePuy Inc.
DePuy Mitek Inc.
KFx Medical Corp.
Kinetic Concepts Inc.
LifeCell Corp.
Lohmann & Rauscher International GMBH & Co. KG
Ortho-Space Ltd.
Pegasus Biologics Inc.
Rensselaer Polytechnic Institute
Revivicor Inc.
Serica Technologies Inc.
Smith & Nephew PLC
Soft Tissue Regeneration Inc.
Stryker Corp.
Tornier SA
University of Virginia
Wright Medical Group Inc.
Xylos Corp.
Zimmer Holdings Inc.
START-UP: No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics. Subscribe to START-UP.





